Introduction
(GFR) (−15%) and filtration fraction (−18%) [14] . The effect is presumably due to nicotine per se, since the findings can be reproduced by chewing nicotineAmongst the health hazards of smoking carcinogenesis containing gum [14] . Based on indirect data it has [1] , cardiovascular disease [1, 2] and lung disease [1, 3] been concluded that in the healthy individual, smoking have attracted considerable attention. In contrast, until causes afferent vasoconstriction, presumably protecting recently the potential impact of smoking on renal the glomerulus against the acute rise in blood pressure. function and renal disease have remained largely unnoIn contrast, in the patient with renal disease, preglomticed [4] . Admittedly, the number of patients with erular vessels are vasodilated. Apparently smoking smoking-related renal problems is considerably smaller induced vasoconstriction is unable to overcome vasothan the number of patients with malignancy, cardiodilation, so that the smoking-induced increase in blood vascular or pulmonary problems, but in view of the pressure can be transmitted into the glomerulus, caushigh cost of renal replacement therapy the problem is ing glomerular hypertension [14] . This hypothesis by no means trivial. Certainly the consequences for requires further confirmation. A recent analysis [15] the health budget are quite considerable [4] .
shows that the renal haemodynamic effects can be There is no doubt that smoking promotes atheroobliterated by pretreatment with b-blockers. Renal genesis in various vessels including the abdominal haemodynamic effects of smoking are apparently aorta [5] and, by implication, plays a prominent role caused by b-adrenergic stimulation, either directly via in the genesis of atherosclerotic renal artery stenosis increased circulating epinephrine, or indirectly via band ischaemic nephropathy [6] [7] [8] . There is also convinadrenergically mediated increase in local angiotensin cing evidence that smoking is one causal factor in the II concentrations. The idea that circulating catecholagenesis of renal cell carcinoma [9] and uroepithelial mines are involved would make sense, since efferent cell carcinoma [10, 11] . We shall restrict, however, the sympathetic nerve traffic, at least to the N. suralis, is discussion to the repercussions of smoking on renal decreased, presumably as a consequence of a barorefunction in subjects without renal disease and in ceptor-mediated response to elevated blood pressure patients with primary renal disease.
[16 ].
The acute effects of smoking on the kidney The chronic effects of smoking on the kidney
Smoking causes intense sympathetic excitation [12] Until now, no information on this aspect had been paralleled by an increase in blood pressure (up to available, but recently some interesting results have 21 mmHg systolic [13] ), tachycardia and increased been reported. Gambaro et al. [17] noted that renal concentrations of catecholamines in the circulation. plasma flow, but not GFR, was lower in chronic Vasoconstriction is noted in many vascular beds, i.e. smokers compared to non-smokers. This was associated with modest elevations in plasma endothelin Correspondence and offprint requests to: Dr Stephan R. Orth, concentrations. Thus, smoking appears to induce funcDepartment Nephrology, University of Heidelberg, Bergheimer Strasse 56a, D-69115 Heidelberg, Germany.
tional abnormalities of the renal vasculature and this is complemented by observations on anatomical abnor-were similar, i.e. 0.73±0.38 ml/min/month and 1.21±0.34 ml/min/month. malities of intrarenal vasculature of smokers [7, 8] . It is of interest that GFR was not found to be decreased Matters are somewhat more complex in type 2 diabetes, since smoking also increases the risk of and this may point to compensatory hyperfiltration of residual nephrons, although other explanations are not subjects to develop type 2 diabetes, possibly because it increases insulin resistance [4] . Nevertheless, the risk excluded. This hypothesis has recently been discussed by Remuzzi [18] and would be in line, amongst others, of smokers to develop microalbuminuria and acceleration of the progression of nephropathy has been equally with the observation that smoking turned out to be a potent predictor of albuminuria in epidemiological well documented in type 2 as in type 1 diabetes.
What is particularly encouraging, however, is the studies [19] [20] [21] .
What is currently unknown is how such renal observation of Sawicki et al. [28] that in patients with type 1 diabetes who had well-controlled HbA1c and damage in chronic smokers without primary renal disease is mediated. Whilst the acute effects mediated blood pressure, the rate of loss of measured GFR was considerably lower in ex-smokers compared to current via sympathetic activation are impressive [14] , one has to consider alternative possibilities of how long-term smokers, i.e. 33% vs 53%. This observation suggests that benefit can be derived from cessation of smoking, injury to the kidney is mediated. In analogy with other vascular beds, endothelial cell damage [22] appears to even in patients with established diabetic nephropathy. play a major role, but complementary possibilities, such as altered prostaglandin metabolism (increased The effects of smoking on progression in patients thromboxane, increased isoprostanes), diminished with non-diabetic renal disease nitric oxide and increased endothelin production, increased interaction with and aggregation of platelets, PMN and monocytes, hypoxic damage from carbon-There has been a report [29] that in patients with lupus nephritis, smoking at the time of onset of nephmonoxide and many others are not excluded. This is a fertile field for further research. The idea of altered ritis was an independent risk factor for the more rapid development of end-stage renal disease, independent nitric oxide handling in the kidney of smokers finds further support in the study of Halimi et al. [23] , who of immunosuppressive or antihypertensive therapy.
Furthermore, a preliminary observation in the Multiple assessed the response of effective renal plasma flow ( ERPF ) and urinary cyclic guanosine monophosphate Risk Factor Intervention Trial suggested a higher risk of end-stage renal failure in smokers compared to non-(cGMP) as an index of nitric oxide action to a 4 mg nicotine gum in non-smokers and chronic smokers. In smokers [30] . Orth et al.
[31] provided strong biostatistical evidence that smoking accelerates progression non-smokers ERPF and GFR decreased by 15% and 14%, respectively, and urinary cGMP decreased by in patients with different forms of inflammatory or non-inflammatory primary renal disease. The salient 51%. In contrast, ERPF and GFR remained unchanged in chronic smokers and cGMP rose by findings of this report are summarized in Table 1 . A matched pair analysis was performed in patients with 87%. Since changes in ERPF induced by nicotine were positively correlated with changes in urinary cGMP either IgA glomerulonephritis or autosomal dominant polycystic kidney disease comparing patients on mainthe authors interpreted that increased cGMP and nitric oxide are responsible for renal tolerance to nicotine in tenance haemodialysis with patients of the outpatient clinic who did not require renal replacement therapy chronic smokers.
(serum creatinine <3 mg/dl ). Matching criteria were renal disease, gender, region of residence, and age at
The effects of smoking on development and renal death of cases. The number of female patients progression of diabetic nephropathy was too small for statistical analysis, but in male smokers, a dose-dependent increase of the odds ratio, i.e. the risk to be on renal replacement therapy, was Diabetologists were the first to notice that patients with type 1 diabetes who smoked had more frequently noted. Consequently, there can be no doubt that smoking aggravates the evolution of primary renal microalbuminuria and overt diabetic nephropathy [24], a finding that meanwhile has been confirmed by numer-diseases. It is currently unresolved whether interference with the acute haemodynamic effects of smoking, parous subsequent investigators [4] . Smoking increases the risk to develop microalbuminuria (relative risk 2.8! ticularly lowering of blood pressure, attenuates the adverse effects of smoking, but the observation is [25] ), shortens the interval from microalbuminuria to overt nephropathy [26 ] and accelerates progression of encouraging that ACE inhibitor treatment apparently abrogates the renal risk of smoking ( Table 1) . nephropathy and loss of GFR. Biesenbach et al. [27] noted that the rate of loss of measured endogenous Recently, Kasiske and Klinger [32] noted higher graft loss in renal transplanted patients; in his retrocreatinine clearance was nearly twice as high in smoking compared to non-smoking type 1 or type 2 diabetic spective analysis, this was accounted for by cardiovascular death with functioning grafts. In an ongoing patients: the rate of loss of GFR in patients with type 1 diabetes was 0.86±0.31 ml/min/month in non-prospective study, this issue is currently addressed by us in collaboration with G. Opelz (Heidelberg, smokers, but 1.24±0.29 ml/min/month in smokers; the respective values for patients with type 2 diabetes Germany), but a preliminary retrospective analysis of Table 1 . Tobacco-associated risk (stratified for ACE-inhibitor treatment and adjusted for systolic blood pressure) to be in end-stage renal failure in male patients with IgA glomerulonephritis (N=44 pairs) and autosomal dominant polycystic kidney disease (N=28 pairs 
